ISPE Names 2026 Pharmaceutical Facility Award Winners
Global manufacturers receive recognition for innovation in sustainable design and automated production technology.
Updated on Oct. 31, 2026 in Healthcare
Live Poll
Do you believe pharmaceutical companies are doing enough to prioritize sustainability in their manufacturing processes?
The International Society for Pharmaceutical Engineering (ISPE) has announced the winners of its 2026 Facility of the Year Awards (FOYA). Several major pharmaceutical companies were honored for advancements ranging from modular infrastructure to sustainable operations.
Why it matters
These awards highlight key industry trends in autonomous manufacturing and environmental efficiency that aim to modernize pharmaceutical supply chains. Recognizing these facilities encourages the adoption of modular, scalable technologies to improve global drug production and patient access.
Takeda's Project AHEAD achieved an 80% reduction in CO2 emissions, saving 1,600 tons of carbon annually. Additionally, Eli Lilly's Concord site completed the development cycle from groundbreaking to FDA approval in 30 months.
The players
ISPE
The International Society for Pharmaceutical Engineering is a global nonprofit association that provides technical and educational resources to pharmaceutical manufacturing professionals.
Sanofi
Sanofi is a French multinational healthcare company that focuses on pharmaceutical research, development, and manufacturing across various therapeutic areas.
Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical corporation known for developing and distributing medical treatments for a wide range of chronic and acute conditions.
Bayer
Bayer is a multinational pharmaceutical and life sciences enterprise that focuses on healthcare and nutrition through extensive global research initiatives.
AstraZeneca
AstraZeneca is a multinational pharmaceutical and biotechnology company that researches and manufactures treatments for diseases in oncology, cardiovascular, and respiratory areas.
The details
Sanofi secured both the Overall and Facility of the Future awards for its Modulus facilities, which utilize inflatable, movable walls to reconfigure production spaces. Bayer also received recognition for its SOLIDA-1 facility, which integrates automated modular lines and customized robotics for autonomous operations.
Timeline
The 2026 FOYA awards were presented in 2026.
The Eli Lilly Concord site began with a groundbreaking in June 2022.
The Eli Lilly Concord site received FDA approval in December 2024.
The deadline for 2027 FOYA award submissions is December 7, 2026.
Market Landscape
The 2026 FOYA awards formalize the industry's shift toward the data-driven and autonomous manufacturing protocols established under the Pharma 4.0 framework. By rewarding modular and robotics-heavy designs, the industry is accelerating its move away from rigid, legacy manufacturing infrastructure.
Increased efficiency in pharmaceutical manufacturing can eventually lower operational costs for firms, which may influence long-term pricing for patients. These innovations also ensure that critical medicines reach the market faster and more reliably during high-demand periods.
The takeaway
The move toward flexible, modular manufacturing facilities allows companies to scale production rapidly in response to shifting global health needs. Industry leaders are increasingly prioritizing sustainability and automation to meet both regulatory requirements and environmental goals.
What happens next
Pharmaceutical companies interested in submitting projects for the 2027 Facility of the Year Awards must finalize their applications by December 7, 2026.
Further reading
Learn more about the latest innovations in pharmaceutical manufacturing by visiting the Healthcare section.
Source note: This article includes information reported by Pharmaceuticalonline.
Live Poll
Do you believe pharmaceutical companies are doing enough to prioritize sustainability in their manufacturing processes?
